Litigation Details for UCB, Inc. v. Mylan Technologies, Inc. (D. Del. 2017)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2017-03-24
Court	District Court, D. Delaware	Date Terminated	2019-08-26
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Parties	MYLAN PHARMACEUTICALS, INC.
Patents	10,130,589; 10,350,174; 6,699,498; 6,884,434; 7,413,747; 8,246,979; 8,246,980; 8,617,591
Attorneys	Eleanor G. Tennyson
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2017-04-19	10		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,699,498 B1; . (Attachments…2017 26 August 2019 1:17-cv-00322 830 Patent None District Court, D. Delaware	External link to document
2017-03-24	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,884,434 B1; 7,413,747 B2; 8,246,979…2017 26 August 2019 1:17-cv-00322 830 Patent None District Court, D. Delaware	External link to document
2019-08-26	92	SO ORDERED	209982), asserting U.S. Patent Nos. 10,130,589 ("the '589 Patent") and 10,350,174 ("…infringement of United States Patent Nos. 6,884,434 ("the ' 434 Patent"), 7,413 ,747 ("…quot;the ' 747 Patent"), 8,246,979 ("the ' 979 Patent"), 8,246,980 ("the …the '980 Patent"), and 8,617,591 ("the ' 591 Patent"), on May 24, 2017 (D.I. 1)…2019 (D.I. 82); WHEREAS the ' 434 Patent was the subject of a recent decision from the United	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document